Nanotechnology brings new hope for metastatic cancer patients
For people facing stage IV cancer, treatments can be limited, with low response rate, and severe side effects. At New Phase, we’re offering hope. Our approach focuses on prolonging patients’ lives while preserving the quality that makes life meaningful.
Precision Cancer Treatment with SARAH Nanoparticles (SaNP)
The technology combines nanoparticles containing multicore superparamagnetic iron oxide coated by a biocompatible polymer which are delivered to the cancer tissues and are heated to 50°C using an Electromagnetic Induction Systems (EIS) which generates an Alternating Magnetic Field (AMF) and applies electromagnetic hyperthermia, causing destruction to the cancer cells since they are more sensitive to heat, leaving healthy cells unharmed
The Treatment Process: Step-by-Step
Nanoparticles (SaNP) containing super paramagnetic iron oxide cores
SaNP injected intravenously into patient
SaNP preferentially delivered to cancer cells via the Enhanced Permeability and Retention (EPR) Effect
SaNP accumulate in malignant tissue
Apply Alternating Magnetic Field (AMF) at 290 kHz using New Phase EIS
SaNP heat malignant cells to 50°C causing cell death
Redefining Stage IV Cancer Treatment with Breakthrough Nanotechnology
Streamlined Regulatory Pathway
New Phase’s technology is designated by the FDA as a medical device, ensuring faster market entry and lower clinical costs in comparison to pharmaceutical drugs
Strong IP
New Phase holds 13 granted patents worldwide, covering precise nanoparticle temperature control and unique amorphous properties.
Clinical Evidence
Over 20 patients have already been treated in early feasibility studies, demonstrating promising safety results and potential for a significant impact on cancer treatment
First-of-its-kind
New Phase offers an innovative, first-of-its-kind life-saving solution for cancer patients who have exhausted all other treatments
Innovating Through Collaboration & Equality
At New Phase we are redefining the boundaries of cancer treatment through innovation and meaningful partnerships. Our groundbreaking achievements based on close collaboration with our scientific experts, medical teams, and regulatory authorities—all share commitment to prolong patients life and improve their quality of life.
Leading-edge research with proven scientific based evidence
Multidisciplinary expertise that drives our innovation across science and technology
Business, scientific and regulatory leadership with a commitment to equality
